-
1
-
-
85026150241
-
Fever, convulsions and coma in scleromyxedema: A 'dermato-neuro syndrome'
-
River Y, Levy I, Gilead L et al. Fever, convulsions and coma in scleromyxedema: a 'dermato-neuro syndrome'. Neurology 1996 46:1778 9.
-
(1996)
Neurology
, vol.46
, pp. 1778-9
-
-
River, Y.1
Levy, I.2
Gilead, L.3
-
2
-
-
0346725885
-
Scleromyxoedema: Treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin
-
Kulczycki A, Nelson M, Eisen A, Heffernan M. Scleromyxoedema: treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin. Br J Dermatol 2003 149:1276 81.
-
(2003)
Br J Dermatol
, vol.149
, pp. 1276-81
-
-
Kulczycki, A.1
Nelson, M.2
Eisen, A.3
Heffernan, M.4
-
3
-
-
0029920574
-
Mechanisms of action of intravenous immune globulin in immune-mediated diseases
-
Mouthon L, Kaveri S, Spalter S et al. Mechanisms of action of intravenous immune globulin in immune-mediated diseases. Clin Exp Immunol 1996 104 (Suppl. 1 3 9.
-
(1996)
Clin Exp Immunol
, vol.104
, Issue.1
, pp. 3-9
-
-
Mouthon, L.1
Kaveri, S.2
Spalter, S.3
-
4
-
-
0033898132
-
Scleromyxedema: Response to high-dose intravenous immunoglobulin (hdIVIg)
-
Lister RK, Jolles S, Whittaker S et al. Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg). J Am Acad Dermatol 2000 43:403 8.
-
(2000)
J Am Acad Dermatol
, vol.43
, pp. 403-8
-
-
Lister, R.K.1
Jolles, S.2
Whittaker, S.3
-
5
-
-
19944427764
-
Effectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: A retrospective review of Mayo Clinic experience
-
Wetter DA, Davis MD, Yiannias JA et al. Effectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experience. Mayo Clin Proc 2005 80:41 7.
-
(2005)
Mayo Clin Proc
, vol.80
, pp. 41-7
-
-
Wetter, D.A.1
Davis, M.D.2
Yiannias, J.A.3
-
6
-
-
21744447373
-
Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins
-
Wojas-Pelc A, Blaszczyk M, Glinska M et al. Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins. J Eur Acad Dermatol Venereol 2005 19:462 5.
-
(2005)
J Eur Acad Dermatol Venereol
, vol.19
, pp. 462-5
-
-
Wojas-Pelc, A.1
Blaszczyk, M.2
Glinska, M.3
-
7
-
-
33645853200
-
Combination oral prednisone and intravenous immunoglobulin in the treatment of scleromyxedema
-
Majeski C, Taher M, Grewal P et al. Combination oral prednisone and intravenous immunoglobulin in the treatment of scleromyxedema. J Cutan Med Surg 2005 9:99 104.
-
(2005)
J Cutan Med Surg
, vol.9
, pp. 99-104
-
-
Majeski, C.1
Taher, M.2
Grewal, P.3
-
8
-
-
0036145088
-
Intravenous immunoglobulins control scleromyxoedema
-
Righi A, Schiavon F, Jablonska S et al. Intravenous immunoglobulins control scleromyxoedema. Ann Rheum Dis 2002 61:59 61.
-
(2002)
Ann Rheum Dis
, vol.61
, pp. 59-61
-
-
Righi, A.1
Schiavon, F.2
Jablonska, S.3
-
9
-
-
2442689242
-
Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin
-
Karim A, Lawlor F, Black MM. Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin. Clin Exp Dermatol 2004 29:317 18.
-
(2004)
Clin Exp Dermatol
, vol.29
, pp. 317-18
-
-
Karim, A.1
Lawlor, F.2
Black, M.M.3
-
10
-
-
34250321375
-
[Marked improvement in scleromyxedema with high-dose intravenous immunoglobulin]
-
Topf S, Simon M Jr., Schell H et al. [Marked improvement in scleromyxedema with high-dose intravenous immunoglobulin]. Hautarzt 2007 58:525 8.
-
(2007)
Hautarzt
, vol.58
, pp. 525-8
-
-
Topf, S.1
Simon Jr., M.2
Schell, H.3
|